The Outeiro laboratory (Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen; Max‐Planck‐Institute for Experimental Medicine, Göttingen, Germany) investigated the cytoskeletal protein vimentin, along with alpha‐synuclein, a soluble protein whose propensity to aggregate is a potential cause for Parkinson's disease (Fig 11). This evidence concerns the gene DNM2 and Parkinson disease.